Clinical trial
Biomarkers of Response to Ketamine in Depression
NCT04216888 is registered in ClinicalTrials.gov with Dan Iosifescu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers of Response to Ketamine in Depression
- Lead sponsor
- Dan Iosifescu
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 26, 2019
- Completion date
- December 28, 2020
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.